Key Highlights
- Cathie Wood’s ARK Invest divested 39,362 shares of Bullish (BLSH) valued at approximately $1.56 million on March 23, distributed between ARKK and ARKW funds
- Bullish stock advanced 4.16% during the same trading session, finishing near $39.55
- Three days prior on March 20, ARK had liquidated 103,379 BLSH shares totaling approximately $3.93 million
- The recent divestments contrast with ARK’s aggressive February 2026 accumulation of about 2.1 million BLSH shares valued at $58–$60 million across nine trading days
- Wall Street analysts maintain a Moderate Buy rating on BLSH, with a consensus price target of $47.83 suggesting approximately 20.9% potential appreciation
Cathie Wood’s investment firm ARK Invest liquidated a total of 39,362 shares of Bullish (BLSH) on Monday, March 23, representing approximately $1.56 million in value, despite the cryptocurrency exchange stock posting a solid 4.16% gain during the session.
The divestment occurred across two exchange-traded funds: ARK Innovation ETF (ARKK) shed 31,154 shares, while ARK Next Generation Internet ETF (ARKW) disposed of 8,208 shares. Bullish shares concluded trading at $39.55.
The March 23 transaction represents part of a broader strategic reduction. Three days earlier on March 20, ARK had already liquidated 103,379 BLSH shares representing approximately $3.93 million — a substantially larger sale that received less market attention than Monday’s transaction.
Combined, the two-day selling activity totals 142,741 shares worth roughly $5.5 million. This reduction follows months of substantial position building by the investment firm.
During February 2026, ARK executed an extended accumulation campaign in BLSH, acquiring roughly 2.1 million shares worth between $58 million and $60 million over nine consecutive trading days. These purchases coincided with a post-earnings decline in the stock price.
Financial Performance Breakdown
Bullish disclosed fourth-quarter 2025 adjusted revenue totaling $92.5 million alongside adjusted EBITDA of $44.5 million, representing year-over-year increases in both metrics. The company’s net loss expanded to $563.6 million, although adjusted net income showed improvement at $28.9 million.
Digital asset transaction volume reached $64.3 billion during the quarter, reflecting a modest sequential decline. Management provided 2026 guidance projecting subscription, services, and related revenue between $220 million and $250 million.
Full-year adjusted operating expenses are forecasted to range from $210 million to $230 million.
Strategic Positioning Behind the Sales
The recent share reduction appears tactical rather than representing a fundamental shift in investment thesis. ARK Invest has consistently demonstrated a pattern of accumulating BLSH during price weakness and trimming positions during strength — Monday’s transaction aligns perfectly with this strategy, occurring as shares rallied over 4%.
Simultaneously, ARK is reallocating capital toward biotechnology opportunities. On the same Monday, the firm acquired 98,722 shares of 10X Genomics (TXG) valued at $1.89 million, coinciding with TXG’s own 4.08% advance.
Cryptocurrency-related equities like Bullish typically exhibit volatility correlated with Bitcoin price movements and regulatory developments, making them logical candidates for partial profit realization following substantial price appreciation.
According to TipRanks data, BLSH maintains a Moderate Buy consensus rating supported by four Buy recommendations and two Hold ratings. Analysts’ average price target of $47.83 indicates potential upside of approximately 20.9% from current trading levels.
